Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:06 PM
Ignite Modification Date:
2025-12-25 @ 8:38 PM
NCT ID:
NCT04447469
Pre Assignment Details:
Participants were divided into 2 cohorts (non-mechanically ventilated and mechanically ventilated) and randomized 1:1:1 to receive a single IV infusion of mavrilimumab (10 mg/kg or 6 mg/kg) or placebo in addition to standard of care. There was a seamless transition in enrollment in both cohorts between the Phase 2 and Phase 3 portions of the study. (For each cohort, once the last participant in Phase 2 was enrolled, all subsequent participants were considered Phase 3 participants.)
Study:
NCT04447469
Study Brief:
Results Section:
NCT04447469